Crossmark

Network Pharmacology and In Vivo Validation Reveal Therapeutic Effects of Sutaehwan in Polycystic Ovary Syndrome by Modulating AMH-AMHR2 Signaling Pathway

Crossref DOI link: https://doi.org/10.1007/s43032-025-02027-x

Published Online: 2025-12-13

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Choi, La Yoon

Kwon, Sujin

So, Sunju

Jeon, Yong-Deok

Kim, Dae Yong

Kim, Mi Hye https://orcid.org/0000-0001-6455-5441
Funding

Funding for this research was provided by:

Korea Health Industry Development Institute (RS-2023-KH138992)
License Information

Text and Data Mining valid from 2025-12-13

Version of Record valid from 2025-12-13
More Information

Article History

Received: 29 June 2025

Accepted: 27 November 2025

First Online: 13 December 2025

Declarations

:

: The animal study was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Woosuk University (Approval No.: WS-2024-22).

: The authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below